Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISTA study: Sublingual nitroglycerin to improve Adamkiewicz artery visualization on CT angiography
jRCTs031250288Recruiting
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of nitroglycerin in Spinal Cord Abnormalities and aortopathy. Primary endpoint: Adamkiewicz artery delineation rate (independent central determination). Started Dec 2025; status: recruiting.
02
Drugs
nitroglycerin
03
Conditions
Spinal Cord Abnormalitiesaortopathy
Beyond the preview
Go deeper on jRCTs031250288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250288.